Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes: 2017-2024

Historic Deferred Taxes for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to -$10.7 million.

  • Organogenesis Holdings' Deferred Taxes fell 74.57% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year change of. This contributed to the annual value of -$10.7 million for FY2024, which is 423.74% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Deferred Taxes is -$10.7 million, which was down 423.74% from $3.3 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Deferred Taxes peaked at $5.4 million during FY2022, and registered a low of -$32.0 million during FY2021.
  • Over the past 3 years, Organogenesis Holdings' median Deferred Taxes value was $3.3 million (recorded in 2023), while the average stood at -$654,000.
  • Per our database at Business Quant, Organogenesis Holdings' Deferred Taxes slumped by 28,650.00% in 2021 and then skyrocketed by 117.03% in 2022.
  • Organogenesis Holdings' Deferred Taxes (Yearly) stood at $112,000 in 2020, then crashed by 28,650.00% to -$32.0 million in 2021, then spiked by 117.03% to $5.4 million in 2022, then tumbled by 39.20% to $3.3 million in 2023, then tumbled by 423.74% to -$10.7 million in 2024.